Speaker Applications Are Now Open
BioPharma Vietnam 2027 brings together pharmaceutical manufacturers, biotech innovators, clinical research leaders, investors, policymakers and solution providers shaping the future of Vietnam's life sciences ecosystem.
As the strategic platform for industry dialogue, collaboration and investment, the summit explores the opportunities, challenges and innovations driving growth across manufacturing, clinical development, market access, investment and advanced therapies.
We are looking for speakers who can share practical experience, actionable insights and real-world lessons that will help define the next phase of Vietnam's biopharma journey.
Help Shape the Conversations That Matter
We are looking for speakers who can contribute practical insights, implementation experience and forward-looking perspectives that support the growth of Vietnam's biopharma ecosystem. Successful submissions will combine strategic relevance with real-world experience, offering delegates valuable lessons they can apply within their own organisations and markets.
We are particularly interested in submissions that:
- Share real-world case studies and implementation lessons.
- Demonstrate measurable impact and practical outcomes.
- Offer strategic perspectives on Vietnam's pharmaceutical and biotech future.
- Highlight successful partnerships, technology transfer or innovation models.
- Explore clinical research, regulation, market access or investment opportunities.
- Provide actionable insights relevant to Vietnam and global markets.
Please note that the Call for Speakers is intended for educational and editorial submissions. Proposals that are primarily promotional or product-focused may be referred to our sponsorship team to explore commercial speaking opportunities.
Featured Themes
Exploring the Priorities Shaping the Future of Biopharma Growth
Pharmaceutical Manufacturing & Localisation
Strengthening domestic manufacturing capabilities through technology transfer, production scale-up, workforce development and internationally recognised quality standards.
Vaccines, Biologics & Advanced Therapies
Advancing vaccine innovation, biologics, precision medicine and advanced therapies to support the next generation of healthcare solutions.
Clinical Research & Development
Developing clinical research infrastructure, partnerships and trial capabilities that support innovation, investment and faster access to new therapies.
Regulatory Affairs & Market Access
Exploring the regulatory, market access and reimbursement pathways that enable innovation, commercial success and patient access.
Supply Chain Resilience & Distribution
Building resilient supply chains, logistics networks and distribution capabilities that support long-term growth and medicine access.
Investment & Industry Partnerships
Connecting investors, industry leaders, researchers and innovators to accelerate commercialisation, capability building and sustainable sector growth.
This year’s programme is built around these core topics:
Strengthening domestic manufacturing capabilities through technology transfer, production scale-up, workforce development and internationally recognised quality standards.
Relevant areas include:
- GMP-compliant manufacturing.
- Technology transfer.
- Localisation strategies.
- Contract manufacturing (CMO/CDMO).
- Production scale-up.
- Manufacturing workforce development.
Advancing vaccine innovation, biologics, precision medicine and advanced therapies to support the next generation of healthcare solutions.
Relevant areas include:
- Vaccine production.
- Biologics manufacturing.
- Sterile manufacturing.
- Aseptic processing.
- Cleanroom and containment systems.
- Advanced production technologies.
Navigating approval frameworks, compliance standards, reimbursement pathways, and commercialisation strategies to accelerate patient access.
Relevant areas include:
- Regulatory compliance.
- Product registration and approval.
- Pharma policy and tendering.
- Market access strategy.
- Reimbursement pathways.
- Pharmaceutical quality standards.
Raising standards across manufacturing, validation, quality systems, and inspection readiness.
Relevant areas include:
- GMP standards.
- Quality management systems.
- Validation and qualification.
- Inspection readiness.
- Manufacturing performance.
- Continuous improvement.
Enhancing cold-chain logistics, distribution networks, and supply continuity to ensure reliable access to medicines across Vietnam and the region.
- Cold chain logistics.
- Distribution networks.
- Inventory planning.
- Supply continuity.
- Pharma traceability.
- Regional supply resilience.
Connecting investors, industry leaders, researchers and innovators to accelerate commercialisation, capability building and sustainable sector growth.
Relevant areas include:
- Foreign direct investment.
- Strategic alliances.
- Public-private partnerships.
- Technology collaboration.
- Industrial park development.
- Market entry and expansion strategy.
Who Should Submit
We welcome proposals from:
Biotech Founders and Innovators
Manufacturing, Quality & Operations Leaders
Clinical Research & CRO Specialists
Regulatory & Market Access Experts
Vaccines, Biologics & Advanced Therapies Experts
Investors & Strategic Partners
Academic Institutions & Research Centres
Be Part of BioPharma Vietnam 2027
Vietnam is entering a defining period of growth for pharmaceuticals, biotechnology and life sciences. This is an opportunity to contribute to the conversations shaping investment, innovation, clinical research, manufacturing and market development across the sector.
Join the leaders shaping Vietnam's biopharma future.
Please take 3–5 minutes to complete the submission form. Our content team reviews every application and will contact shortlisted speakers directly.
